Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N Jones

Showing results (231-240 of 945) with videos related to

Pageof 95
Sort By:
Psychological Medicine|July 7, 2000
Dimensions of the Mini-Mental State Examination among community dwelling older adultsR N Jones, J J Gallo
Drugs|March 16, 2000
Oxazolidinones: a reviewD I Diekema, R N Jones
The Journal of Antimicrobial Chemotherapy|September 1, 1988
Antimicrobial activity of LY163892, an orally administered 1-carbacephemR N Jones, A L Barry
Diagnostic Microbiology and Infectious Disease|January 5, 2002
Assessment of BMS284756 MIC and 5-microg disk diffusion quality control studies tested against seven American type culture collection strainsD J Biedenbach, R N Jones,
Lancet (London, England)|December 19, 2001
Oxazolidinone antibioticsD J Diekema, R N Jones
Diagnostic Microbiology and Infectious Disease|June 19, 2001
Can antimicrobial susceptibility testing results for ciprofloxacin or levofloxacin predict susceptibility to a newer fluoroquinolone, gatifloxacin?: Report from The SENTRY Antimicrobial Surveillance Program (1997-99)R N Jones, M A Pfaller,
Diagnostic Microbiology and Infectious Disease|March 1, 1995
National survey of the in vitro spectrum of piperacillin-tazobactam tested against more than 40,000 aerobic clinical isolates from 236 medical centersE J Baron, R N Jones
Antimicrobial Agents and Chemotherapy|July 1, 1995
In vitro evaluation of DV-7751a, a new fluoroquinolone with an enhanced spectrum of activity against gram-positive aerobic organisms and anaerobesD J Biedenbach, R N Jones
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 1, 1993
Antimicrobial activity of the new carbapenem biapenem compared to imipenem, meropenem and other broad-spectrum beta-lactam drugsH S Sader, R N Jones
The Journal of Antimicrobial Chemotherapy|October 1, 1993
Roxithromycin in-vitro susceptibility testing of Haemophilus influenzae by NCCLS methods. National Committee for Clinical Laboratory StandardsM E Erwin, R N Jones
Pageof 95

Showing results (231-240 of 945) with videos related to

Sort By:
Pageof 95
Psychological Medicine|July 7, 2000
Dimensions of the Mini-Mental State Examination among community dwelling older adultsR N Jones, J J Gallo
Drugs|March 16, 2000
Oxazolidinones: a reviewD I Diekema, R N Jones
The Journal of Antimicrobial Chemotherapy|September 1, 1988
Antimicrobial activity of LY163892, an orally administered 1-carbacephemR N Jones, A L Barry
Diagnostic Microbiology and Infectious Disease|January 5, 2002
Assessment of BMS284756 MIC and 5-microg disk diffusion quality control studies tested against seven American type culture collection strainsD J Biedenbach, R N Jones,
Lancet (London, England)|December 19, 2001
Oxazolidinone antibioticsD J Diekema, R N Jones
Diagnostic Microbiology and Infectious Disease|June 19, 2001
Can antimicrobial susceptibility testing results for ciprofloxacin or levofloxacin predict susceptibility to a newer fluoroquinolone, gatifloxacin?: Report from The SENTRY Antimicrobial Surveillance Program (1997-99)R N Jones, M A Pfaller,
Diagnostic Microbiology and Infectious Disease|March 1, 1995
National survey of the in vitro spectrum of piperacillin-tazobactam tested against more than 40,000 aerobic clinical isolates from 236 medical centersE J Baron, R N Jones
Antimicrobial Agents and Chemotherapy|July 1, 1995
In vitro evaluation of DV-7751a, a new fluoroquinolone with an enhanced spectrum of activity against gram-positive aerobic organisms and anaerobesD J Biedenbach, R N Jones
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 1, 1993
Antimicrobial activity of the new carbapenem biapenem compared to imipenem, meropenem and other broad-spectrum beta-lactam drugsH S Sader, R N Jones
The Journal of Antimicrobial Chemotherapy|October 1, 1993
Roxithromycin in-vitro susceptibility testing of Haemophilus influenzae by NCCLS methods. National Committee for Clinical Laboratory StandardsM E Erwin, R N Jones
Pageof 95